ESRP1-RAF1 fusion
|
Prostate Cancer
|
ESRP1-RAF1 fusion
|
Prostate Cancer
|
sorafenib Sensitive: D – Preclinical
|
sorafenib Sensitive: D – Preclinical
|
ESRP1-RAF1 fusion
|
Prostate Cancer
|
ESRP1-RAF1 fusion
|
Prostate Cancer
|
U0126 Sensitive: D – Preclinical
|
U0126 Sensitive: D – Preclinical
|